Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients Benoit MilcentNathalie JosseaumeSophie Sibéril Original Article Open access 07 September 2019 Pages: 1561 - 1572
Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression Vasiliki SiozopoulouElly MarcqPatrick Pauwels Original Article 11 September 2019 Pages: 1573 - 1583
Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients Estefanía Paula JuliáPablo MandóEstrella Mariel Levy Original Article 12 September 2019 Pages: 1585 - 1596
ANTXR1 (TEM8) overexpression in gastric adenocarcinoma makes the protein a potential target of immunotherapy Masoud SotoudehRamin ShakeriMahmood Naderi Original Article 14 September 2019 Pages: 1597 - 1603
Induction of tumor-specific CD8+ cytotoxic T lymphocytes from naïve human T cells by using Mycobacterium-derived mycolic acid and lipoarabinomannan-stimulated dendritic cells Yuji TomitaEri WatanabeHidemi Takahashi Original Article Open access 17 September 2019 Pages: 1605 - 1619
The BRCA2 mutation status shapes the immune phenotype of prostate cancer Maximilian JenzerPeter KeßStefan Duensing Original Article Open access 23 September 2019 Pages: 1621 - 1633
Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment Nicholas OsborneRebecca SundsethJill P. Smith Original Article 24 September 2019 Pages: 1635 - 1648
PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitor Akiko FujimuraKazunori NakayamaHideya Onishi Original Article 27 September 2019 Pages: 1649 - 1660
Increased indoleamine 2,3-dioxygenase activity and expression in prostate cancer following targeted immunotherapy Chris D. ZahmLaura E. JohnsonDouglas G. McNeel Original Article 12 October 2019 Pages: 1661 - 1669
The role of immune infiltrates as prognostic biomarkers in patients with breast cancer Constantin N. BaxevanisMichael SofopoulosSonia A. Perez Focussed Research Review 23 March 2019 Pages: 1671 - 1680
Unlocking the therapeutic potential of primary tumor-draining lymph nodes Jossie RotmanBas D. KosterTanja D. de Gruijl Focussed Research Review Open access 03 April 2019 Pages: 1681 - 1688
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy Michael FriedrichSimon Jasinski-BergnerBarbara Seliger Focussed Research Review 03 August 2019 Pages: 1689 - 1700
T cell engineering for adoptive T cell therapy: safety and receptor avidity Elvira D’IppolitoKilian SchoberDirk H. Busch Focussed Research Review 21 September 2019 Pages: 1701 - 1712
Conventional CARs versus modular CARs Anja FeldmannClaudia ArndtMichael P. Bachmann Focussed Research Review Open access 21 September 2019 Pages: 1713 - 1719
Natural killer cells control metastasis via structural editing of primary tumors in mice Batya IsaacsonOfer Mandelboim Focussed Research Review 13 October 2019 Pages: 1721 - 1724
“Tumor Immunology Meets Oncology (TIMO) XIV”, May 24–26th 2018, Halle/Saale, Germany André StevenBarbara Seliger Meeting Report 04 April 2019 Pages: 1725 - 1732